111 related articles for article (PubMed ID: 19276868)
1. Identification and characterization of a novel anticancer agent with selectivity against deleted in pancreatic cancer locus 4 (DPC4)-deficient pancreatic and colon cancer cells.
Wang H; Stephens B; Von Hoff DD; Han H
Pancreas; 2009 Jul; 38(5):551-7. PubMed ID: 19276868
[TBL] [Abstract][Full Text] [Related]
2. Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
Wang H; Han H; Von Hoff DD
Cancer Res; 2006 Oct; 66(19):9722-30. PubMed ID: 17018631
[TBL] [Abstract][Full Text] [Related]
3. UA62784, a novel inhibitor of centromere protein E kinesin-like protein.
Henderson MC; Shaw YJ; Wang H; Han H; Hurley LH; Flynn G; Dorr RT; Von Hoff DD
Mol Cancer Ther; 2009 Jan; 8(1):36-44. PubMed ID: 19139111
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer.
Hao J; Zhang S; Zhou Y; Hu X; Shao C
FEBS Lett; 2011 Jan; 585(1):207-13. PubMed ID: 21112326
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer.
Hao J; Zhang S; Zhou Y; Liu C; Hu X; Shao C
Biochem Biophys Res Commun; 2011 Mar; 406(4):552-7. PubMed ID: 21352803
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.
Wilentz RE; Su GH; Dai JL; Sparks AB; Argani P; Sohn TA; Yeo CJ; Kern SE; Hruban RH
Am J Pathol; 2000 Jan; 156(1):37-43. PubMed ID: 10623651
[TBL] [Abstract][Full Text] [Related]
8. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
[TBL] [Abstract][Full Text] [Related]
9. High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.
Sohn TA; Su GH; Ryu B; Yeo CJ; Kern SE
Ann Surg; 2001 May; 233(5):696-703. PubMed ID: 11323508
[TBL] [Abstract][Full Text] [Related]
10. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a membrane-active anti-tumor agent, UA8967.
Dorr RT; Samulitis BK; Wisner L; Han H; Zhao Y; Beroza P; Damodaran K; Igarashi S; Landowski TH; Von Hoff DD
Invest New Drugs; 2013 Jun; 31(3):576-86. PubMed ID: 23179338
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
14. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
[TBL] [Abstract][Full Text] [Related]
15. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer].
Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF
Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060
[TBL] [Abstract][Full Text] [Related]
16. Role of p21CIP1 as a determinant of SC-560 response in human HCT116 colon carcinoma cells.
Lee E; Choi MK; Han IO; Lim SJ
Exp Mol Med; 2006 Jun; 38(3):325-31. PubMed ID: 16819292
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL
Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405
[TBL] [Abstract][Full Text] [Related]
18. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
19. Effect of deleted pancreatic cancer locus 4 gene transfection on biological behaviors of human colorectal carcinoma cells.
Xiao DS; Wen JF; Li JH; Hu ZL; Zheng H; Fu CY
World J Gastroenterol; 2005 Jan; 11(3):348-52. PubMed ID: 15637742
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of diallyl disulfide in cell cycle arrest and apoptosis in HCT-116 colon cancer cells.
Song JD; Lee SK; Kim KM; Park SE; Park SJ; Kim KH; Ahn SC; Park YC
J Biochem Mol Toxicol; 2009; 23(1):71-9. PubMed ID: 19202565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
